ATOM vs BIO · rev $135.0K vs rev $2.58B
Atomera Inc (ATOM) versus BIO (BIO) — a side-by-side from cached financials, not a winner call.
Atomera Inc (ATOM) is a semiconductor equipment & materials company listed on US.
BIO (BIO) common stock.
Latest reported ATOM revenue for 2024-12-31 was $135.0K. Net income was -$18.4M. Revenue was down 75.5% from 2023-12-31 to 2024-12-31. ATOM currently screens at market cap $341.1M.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
ATOM currently screens at market cap $341.1M. BIO currently screens at market cap $0.
Not investment advice. Open the ATOM and BIO stock pages for the full models.
Not investment advice.